This 2004 review outlines the use of subcutaneous estradiol pellet implants for estrogen replacement therapy in postmenopausal women. The procedure involves a minor office-based insertion of 25 mg estradiol pellets into the lower abdomen or buttocks. This method achieves physiologic estradiol levels and suppresses follicle-stimulating hormone (FSH), mirroring premenopausal hormonal
A pilot study investigated the effects of hormone replacement therapy (HRT) on sleep-disordered breathing (SDB) in six postmenopausal women with mild to moderate SDB. Polysomnography was conducted at baseline, after 7-12 days of estrogen therapy, and again after an additional 7-13 days of combined estrogen and progesterone therapy. Estrogen alone
This article reviews the use of oral micronized progesterone as a preferred alternative to synthetic progestins in hormone replacement therapy for postmenopausal women. It highlights that while unopposed estrogen therapy increases the risk of endometrial hyperplasia and cancer, the addition of progesterone effectively mitigates this risk. Micronized progesterone, with comparable
This review article discusses the impact of menopausal hormone therapy (HRT) on improving the quality of life in symptomatic menopausal women. It highlights the benefits of HRT in alleviating symptoms such as hot flashes, night sweats, and mood disturbances, emphasizing that the therapy significantly improves overall well-being. The review also
